首页> 外文期刊>American Journal of Surgical Pathology >Recurrent DICER1 Hotspot Mutations in Malignant Thyroid Gland Teratomas
【24h】

Recurrent DICER1 Hotspot Mutations in Malignant Thyroid Gland Teratomas

机译:复发性Dicer1恶性甲状腺腺畸胎瘤中的热点突变

获取原文
获取原文并翻译 | 示例
       

摘要

Thyroid gland teratomas are rare tumors that span a wide clinicopathologic spectrum. Although benign and immature teratomas arise in infants and young children and generally have good outcomes, malignant teratomas affect adults and follow an aggressive course. This divergent behavior raises the possibility that benign/immature and malignant teratomas are separate entities rather than different grades of a single tumor. However, the histogenesis and molecular underpinnings of thyroid gland teratomas are poorly understood regardless of grade. In this study, we performed next-generation sequencing on 8 thyroid gland teratomas, including 4 malignant, 3 benign, and 1 immature. We identified DICER1 hotspot mutations in all 4 malignant cases (100%) but not in any benign/immature cases (0%). No clinically significant mutations in other genes were found in either group. We also performed immunohistochemistry to characterize the primitive components of malignant teratomas. Not only did all cases consistently contain immature neural elements (synaptophysin and INSM1 positive), but also spindled cells with rhabdomyoblastic differentiation (desmin and myogenin positive) and bland epithelial proliferations of thyroid follicular origin (TTF-1 and PAX8 positive). Although DICER1 mutations have previously been implicated in multinodular hyperplasia and well-differentiated thyroid carcinomas, these findings demonstrate the first recurrent role for DICER1 in primitive thyroid tumors. The combined neural, rhabdomyoblastic, and homologous epithelial elements highlighted in this series of malignant thyroid gland teratomas parallel the components of DICER1 -mutated tumors in other organs. Overall, these molecular findings further expand the differences between benign/immature teratomas and malignant teratomas, supporting the classification of these tumors as separate entities.
机译:甲状腺畸胎瘤是突出临床病理光谱的罕见肿瘤。虽然婴儿和幼儿出现良性和未成熟的畸胎瘤,但通常具有良好的结果,恶性畸胎瘤影响成年人并遵循一个侵略性的课程。这种不同的行为引发了良性/未成熟和恶性畸胎瘤的可能性是单独的实体而不是不同患者的单一肿瘤等级。然而,无论等级如何,甲状腺畸胎瘤的组织和分子底有不知所措。在这项研究中,我们在8个甲状腺畸胎瘤上进行下一代测序,包括4个恶性,3个良性和1个未成熟。我们在所有4个恶性病例中鉴定了Dicer1热点突变(100%),但不含任何良性/未成熟病例(0%)。在任一组中发现了其他基因中的临床上显着的突变。我们还表现了免疫组织化学来表征恶性畸胎瘤的原始成分。所有病例不仅始终含有未成熟的神经元素(Sypaptophysin和Insm1阳性),还含有横纹卵泡分化(Desmin和Myogenin阳性)的纺织细胞和甲状腺卵泡突发的平坦上皮增殖(TTF-1和PAX8阳性)。虽然Dicer1突变先前涉及多内型增生和分化良好的甲状腺癌,但这些研究结果证明了Dicer1在原始甲状腺肿瘤中的第一种复发作用。在本系列恶性甲状腺畸胎瘤中突出的组合神经,横纹肌和同源上皮元素平行于其他器官中的Dicer1-矫正肿瘤的组分。总体而言,这些分子结果进一步扩大了良性/未成熟畸胎瘤和恶性畸胎瘤之间的差异,支持这些肿瘤的分类为单独的实体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号